Breast cancer prognostic markers in the post-genomic era.
Pusztai
Lajos
L
Department of Breast Medical Oncology, UT MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. lpusztai@mdanderson.org
Iwamoto
Takayuki
T
D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D018572:Disease-Free Survival; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D008207:Lymphatic Metastasis; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D012333:RNA, Messenger / Q000378:metabolism; D012008:Recurrence; D013997:Time Factors
D014408:Biomarkers, Tumor; D012333:RNA, Messenger